Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC study

Hypertension

Volumn 30, Issue 5, 1997, Pages 1135-1143

  Pontremoli, Roberto ^a   Sofia, Antonella ^a   Ravera, Maura ^a   Nicolella, Clizia ^a   Viazzi, Francesca ^a   Tirotta, Angelito ^a   Ruello, Natia ^a   Tomolillo, Cinzia ^a   Castello, Cristoforo ^c   Grillo, Giuliano ^d   Sacchi, Giorgio ^b   Deferrari, Giacomo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Albuminuria; Cardiovascular damage; Hypertension, essential; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; URINARY EXCRETION;

EID: 0030720863     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1135     Document Type: Article

References (42)

1. Yudkin JS, Forrest RD, Jackson C. Microalbuminuria as predictor of vascular disease in non diabetic subjects. Lancet. 1988;2:530-533.
2. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J. 1990;300:297-300.
3. West JNW, Gosling P, Dimmitt SB, Littler WA. Non diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci. 1991;81:101-105.
4. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron. 1992;61:94-97.
5. Agewall S, Persson B, Samuelsson O, Ljungman S, Herlitz H, Fagerberg B. Microalbuminuria in treated hypertensive men at high risk of coronary disease: the Risk Factor Intervention Study Group. J Hypertens. 1993;11:461-469.
6. Mimram A, Ribstein J, DuCailar G, Halimi J-M. Albuminoria in normal and essential hypertension. J Diabetes Complications. 1994; 8:150-156.
7. Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension. 1994;24:101-105.
8. James AM, Fotherby MD, Potter JF. Microalbuminuria in elderly hypertensives: reproducibility and relation to clinic and ambulatory blood pressure. J Hypertens. 1994;12:309-314.
9. James AM, Fotherby MD, Potter JF. Screening test for microalbuminuria in non diabetic elderly subjects and their relation to blood pressure. Clin Sci. 1995;88:185-190.
10. Summerson JH, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis. 1995;26:577-579.
11. Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, Gregori S, Garavelli G, Pegoraro F, Maraglino G, Bortolazzi A, Accurso V, Dorigatti F, Graniero F, Gelisio R, Businaro R, Vriz O, Dal Folio M, Camarotto A, Pessina AC. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Am J Hypertens. 1996;89:334-341.
12. Erley CM, Risler T. Microalbuminuria in primary hypertension: is it a marker of glomerular damage? Nephrol Dial Transplant. 1994; 9:1713-1715.
13. Pedrinelli R, Di Bello V, Catapano G, Talarico L, Materazzi F, Santoro G, Giusti C, Mosca F, Melillo E, Ferrari M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscler Thromb. 1993;13:900-906.
14. Bianchi S, Bigazzi R, Campese VM. Increased cardiovascular events in patients with hypertension and microalbuminuria. J Am Soc Nephrol. 1996;7:1546. Abstract.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
16. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi G, for the Italian Microalbuminuria Study Group. Prevalence of hypertension and microalbuminuria in adult type 1 (insulin dependent) diabetic patients without renal failure in Italy: validation of screening techniques to detect albuminuria. Acta Diabetol. 1992;29:156-166.
17. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization Monograph Series, No 56; 1968:1-188.
18. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final reports of the Pooling Project. J Chronic Dis. 1978;31:201-306.
19. Keith NM, Wagener HP, Barker MW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939;197:332-343.
20. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. Ames, Iowa: Ames Iowa State University Press; 1967.
21. Weisberg S. Applied Linear Regression. New York, NY: John Wiley & Sons Inc; 1980:1-283.
22. Tryon RC, Bailey DE. Cluster Analysis. New York, NY: McGraw-Hill Book Co; 1970:1-347.
23. Zavaroni I, Bonini L, Gasparini P, Zuccarelli A, Dall'Aglio E, Barilli L, Cioni F, Strata A, Reaven GM. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population. J Intern Med. 1996;240:151-156.
24. Ritz E, Nowicki M, Fliser D, Horner D, Klimm HP. Proteinuria and hypertension. Kidney Int. 1994;46(suppl 47):S76-S80.
25. Woo J, Cockram CS, Swaminathan R, Lau E, Chan A, Cheung R. Microalbuminuria and other cardiovascular risk factors in non diabetic subjects. Int J Cardiol. 1992;37:345-350.
26. Gould M, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Microalbuminuria: association with height and sex in non diabetic subjects. Br Med J. 1993;306:240-242.
27. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 1992;93:71-81.
28. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens. 1994;12: 947-953.
29. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989;2:419-423.
30. Facchini F, Chen I, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA. 1991; 266:3008-3011.
31. Bianchi S, Bigazzi R, Quinones Galvan A, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferrannini E, Natali A. Insulin resistance in microalbuminuric hypertension: sites and mechanisms. Hypertension. 1995;26:789-795.
32. Pedrinelli R, Gianpietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994;344:14-18.
33. Redon J, Youlian L, Lozano JV, Miralles A, Baldo E, Cooper RS. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:801-807.
34. Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Goteborg, Sweden. J Hypertens. 1985;3:167-176.
35. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1970;72:813-822.
36. Sullivan JM, Vander Zwaag R, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol. 1993;22:508-513.
37. Schouten EG, Vandenbroucke JP, Van Der Heide-Wessel C, Van Der Heide RM. Retinopathy as an independent indicator of all-causes mortality. Int J Epidemiol. 1986;15:234-236.
38. Schmieder R, Grube E, Ruddel H, Schlebush H, Schulte W. Microproteinuria as a marker for target organ damage in essential hypertension. Klin Wochenschr. 1990;68:256-262.
39. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E, Nardi E, Andronico G, Fulantelli MA, Marcellino T, Seddio G. Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens. 1989;7(suppl 6): S332-S333.
40. Biesenbach G, Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol. 1994;41:211-218.
41. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens. 1995;9: 827-833.
42. Del Sette M, Zagami P, Angeli S, Finocchi C, Gandolfo C, Pontremoli R. Carotid diameter, wall thickness, and parietal stress in essential hypertension. Stroke. 1995;26:2373-2374.